Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4537 (miR-4537) is a small non-coding RNA molecule involved in the post-transcriptional regulation of gene expression. In gastric cancer, miR-4537 acts as a tumor suppressor by suppressing cell proliferation, promoting apoptosis, and increasing radiosensitivity of cancer cells. Its expression is downregulated in gastric cancer tissues compared to normal tissues, and it directly targets genes such as zinc finger protein 587 (ZNF587), negatively regulating their expression. Modulation of miR-4537 has potential implications for enhancing the effectiveness of radiotherapy in gastric cancer[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4537 (miR-4537).